RPL7P23

Across TCGA pan-cancer cohorts, RPL7P23 RNA is linked to patient survival in 26 of 34 cancer types, making it the most broadly survival-associated RPL7P23 data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher RPL7P23 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RPL7P23 expression acts as an unfavorable survival marker, although some lineages such as THCA and LUSC show a favorable association.

UVM, ACC, and LIHC are the cancer types where RPL7P23 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	DFS	Median	III,IV	0.296	0.758	<.001	90	view →
ACC	DFS	Tertile	All	0.224	0.647	<.001	75	view →
LIHC	OS	Quartile	All	0.585	0.799	<.001	46	view →
SARC	OS	Median	All	0.423	0.605	<.001	43	view →
THCA	DFS	Median	All	0.892	0.770	.005	39	view →
LUSC	OS	Quartile	All	0.767	0.581	.001	39	view →
OV	OS	Tertile	II,III,IV	0.265	0.376	.008	38	view →
LGG	OS	Median	All	0.863	0.749	<.001	36	view →
CHOL	OS	Median	II,III,IV	0.875	0.271	.003	28	view →
UCEC	DFS	Tertile	All	0.532	0.808	.001	26	view →
MESO	DFS	Median	III,IV	0.667	0.234	.004	24	view →
CESC	OS	Tertile	IV	0.074	0.726	.005	24	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 26 lineages.

RPL7P23–UVM (DFS)

Open the UVM breakdown →